Intellipharmaceutics: Fiscal 2Q Earnings Snapshot

TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCIF) on Wednesday reported a loss of $1 million in its fiscal second quarter.

The Toronto-based company said it had a loss of 4 cents per share.

The extended-release drug developer posted revenue of $395,700 in the period. Its adjusted revenue was $396,000.

In the final minutes of trading on Wednesday, the company’s shares hit 14 cents. A year ago, they were trading at 22 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IPCIF at https://www.zacks.com/ap/IPCIF

The Associated Press